Dietary flavonoid and cancer prevention: Evidence and potential mechanism

Critical Reviews in Oncogenesis

Volumn 8, Issue 1, 1997, Pages 47-69

  Kuo, Shiu Ming ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antioxidant; Development; Genistein; Quercetin; Type II estrogen binding sites

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; CARCINOGEN; CISPLATIN; CYTARABINE; DNA TOPOISOMERASE; DOXORUBICIN; ESTROGEN RECEPTOR; FLAVAN DERIVATIVE; FLAVANOL DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; FREE RADICAL; GENISTEIN; ISOFLAVONE DERIVATIVE; LIGAND; POLYPHENOL; PROTEIN KINASE; QUERCETIN; STEROID HORMONE;

APOPTOSIS; CANCER INCIDENCE; CANCER PREVENTION; CELL DIFFERENTIATION; CHEMICAL CARCINOGENESIS; DIETARY INTAKE; HUMAN; NONHUMAN; RADIATION CARCINOGENESIS; RECEPTOR AFFINITY; REVIEW; STEROID METABOLISM;

EID: 0031431501     PISSN: 08939675     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevOncog.v8.i1.30     Document Type: Review

References (223)

1. Adams, N. R.: Organizational and activational effects of phytoestrogens on the reproductive tract of the ewe. Proc. Soc. Exp. Biol. Med., 208:87-91 (1995).
2. Adlercreutz, H., Y. Mousavi, J. Clark, K. Hockerstedt, E. Hamalainen, K. Wahala, T. Makela, and T. Hase: Dietary phytoestrogens and cancer: in vitro and in vivo studies. J. Steroid Biochem. Molec. Biol., 41:331-337 (1992).
3. Adlercreutz, H.: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ. Health Perspect., 103S:103-112 (1995).
4. Afanas'ev, I. B., A. I. Dorozhko, A. V. Brodskii,V. A. Kostyuk, and A. I. Potapovitch: Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol., 38:1763-1769 (1989).
5. Agullo, G., L. Gamet, C. Besson, C. Demigne, and C. Remesy: Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT-29 and Caco-2 cells. Cancer Lett., 87:55-63 (1994).
6. Ahmed, M. S., F. Fazal, A. Ramesh, S. M. Hadi, and J. H. Parish: Activities of flavonoids for th cleavage of DNA in the presence of Cu(II): correlation with generation of active oxygen species. Carcinogenesis, 13:605-608 (1992).
7. Akagi K., M. Hirose, T. Hoshiya, Y. Mizoguchi, N. Ito, and T. Shirari: Modulation effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett., 94:113-121 (1995).
8. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami: Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262:5592-5595 (1987).
9. Anthony, M. S., T. S. Clarkson, C. L. Hughes, Jr., T. M. Morgan, and G. L. Burke: Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal Rhesus monkeys. J. Nutr., 126:43-50 (1996).
10. Baba, S., T. Furuta, M. Fujioka, and T. Goromaru: Studies on drug metabolism by use of isotopes XXVII: Urinary metabolites of rutin in rats and the role of intestinal microflora in the metabolism of rutin. J. Pharmacol. Sci., 72:1155-1158 (1983).
11. Baird, D. D., D. M. Umbach, L. Lansdell, C. L. Hughes, K. D. R. Setchell, C. R. Weinberg, A. F. Haney, A. J. Wilcox, and J. A. McLachlan: Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J. Clin. Endocrinol. Metab., 80:1685-1690 (1995).
12. Barnes, S., M. Kirk, and L. Coward: Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J. Agric. Food Chem., 42:2466-2474 (1994).
13. Barnes, S: Effect of genistein on in vitro and in vivo models of cancer. J. Nutr., 125:777S-783S (1995).
14. Barnes, S., T. G. Peterson, and L. Coward: Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J. Cell. Biochem., 22S:181-187 (1995).
15. Baron, J. A., E. R. Greenberg, R. Haile, J. Mandel, R. S. Sandlers, and L. Mott: Coffee and tea and the risk of recurrent colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 6:7-10 (1997).
16. Bartholomew, R. M. and D. S. Ryan: Lack of mutagenicity of some phytoestrogens in the salmonella/mammalian microsome assay. Mutation Res., 78:317-321 (1980).
17. Bergan, R., E. Kyle, P. Nguyen, J. Trepel, C. Ingui, and L. Neckers: Genistein-stimulated adherence of prostate cancer cells is associated with the binding of focal adhesiion kinase to β1-integrin. Clin. Exp. Metastasis, 14:389-398 (1996).
18. Birt, D. F., D. Mitchell, B. Gold, P. Pour, and H. C. Pinch: Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. Anticancer Res., 17:85-91 (1997).
19. Bjeldanes, L.F. and G. W. Chang: Mutagenic activity of quercetin and related compounds. Science, 197:577-578 (1977).
20. Bokemeyer, C., L. M. Fels, T. Dunn, W. Voigt, J. Gaedeke, H. J. Schmoll, H. Stolte, and H. Lentzen: Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumor activity. Br. J. Cancer, 74:2036-2041 (1996).
21. Bokkenheuser, V.D., C. H. L. Shackleton, and J. Winter: Hydrolysis of dietary flavonoid glycosides by strains of intestinal bacteroides from human. Biochem. J., 248:953-956 (1987).
22. Bracke, M. E., E. A. Bruyneel, S. J. Vermeulen, K. Vennekens, V. V. Marck, and M. M. Mareel: Citrus flavonoid effect on tumor invasion and metastasis. Food Technol., 48(11):121-124 (1994).
23. Brandi, M. L.: Natural and synthetic isoflavones in the prevention and treatment of chronic diseases. Calcif. Tissue Int., 61:S5-S8 (1997).
24. Brzezinski, A., H. Adlercreutx, R. Shaoul, A. Rosler, A. Shmueli, V. Tanos, and J. G. Schenker: Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 4:89-94 (1997).
25. Cai, Q. and H. Wei: Efect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr. Cancer, 25:1-7 (1996).
26. Caltagirone, S., F. O. Ranelletti, A. Rinelli, N. Maggiano, A. Colasante, P. Musiani, F. B. Aiello and M. Piantelli: Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small cell lung cancer. Am. J. Respir. Cell. Mol. Biol., 17:51-59 (1997).
27. Cantrell J. S.: Crystal structures, bonding, and hydrogen bonding in flavonoids compounds. In: Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships (V. Cody, E. Middleton and J. B. Horborne, Eds.) Alan R. Liss, New York, 391-394 (1986).
28. Cassidy, A., S. Bingham, and K. D. R. Setchell: Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60:333-340 (1994).
29. Castillo, M.H., E. Perkins, J. H. Campbell, R. Doerr, J. M. Hassett, C. Kandaswami, and E. Middleton, Jr.: The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am. J. Surg., 158:351-355 (1989).
30. Chae, Y.-H., S. L. Coffing, V. M. Cook, D. K. Ho, J. M. Cassady, and W. M. Baird: Effects of biochanin A on metabolism, DNA binding and mutagenisity of benzo[a]pyrene in mammalian cell cultures. Carcinogenesis, 12:2001-2006 (1991).
31. Clark, J. H., J. W. Hardin, S. Upchurch, and H. Eriksson: Heterogeneity of estrogen binding sites in the cytosol of the rat uterus. J. Biol. Chem., 253:7630-7634 (1978).
32. Constantinou, A., K. Kiguchi, and E. Huberman: Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res., 50:2618-2624 (1990).
33. Constantinou, A. and E. Huberman: Genistein as an inducer of tumor cell differentiation: possible mechanisms of action. Proc. Soc. Exp. Biol. Med., 208:109-115 (1995).
34. Constantinou, A. I., R. G. Mehta, and A. Vaughan: Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res., 16:3293-3298 (1996).
35. Cotelle, N., J.-L. Bernier, J. P. Catteau, J. Pommery, J.-C. Wallet, and E. M. Gaydou: Antioxidant properties of hydroxyl-flavones. Free Radic. Biol. Med., 20:35-43 (1996).
36. Dangles, V., F. Femenia, V. Laine, M. Berthelemy, D. Le Rhun, M. F. Poupon, D. Levy, and I. Schwartz-Cornil: Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines. Cancer Res., 57:3360-3364 (1997).
37. Das, M. and P. K. Ray: Lipid antioxidant properties of quercetin in vitro. Biochem. Int., 17:203-209 (1988).
38. Dees, C., J. S. Foster, S. Ahamed, and J. Wimalasena: Dietary estrogens stimulate human breast cells to enter the cell cycle. Environ. Health Perspect., 105S:633-636 (1997).
39. Denarie, J., F. Debelle, and C. Rosenberg: Signaling and host range variation in nodulation. Ann. Rev. Microbiol., 46:497-531 (1992).
40. Densmore, C. L., B. M. Markaverich, B. W. O'Malley, and J. H. Clark: Characterization and partial purification of an estrogen type II binding site in chick oviduct cytosol. Biochemistry, 28:7788-7796 (1989).
41. Densmore, C. L., T. H. Schauweker, R. R. Gregory, B. Webb, E. Garcia, and B. M. Markaverich: Chromatographic resolution of the type II estrogen binding site and a tyrosinase-like enzymatic activity from rat uterine nuclei. Steroids, 59:282-287 (1994).
42. Deschner, E. E., J. Ruperto, G. Wong, and H. L. Newmark: Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis, 12:1193-1196 (1991).
43. Djordjevic, M. A., J. W. Redmond, M. Batley, and B. G. Rolfe: Clovers secrete specific phenolic compounds which either stimulate or repress nod gene expression in Rhizobium trifolii. EMBO J., 6:1173-1179 (1987).
44. Dorozhko, A. I., A. V. Brodskii, and I. B. Afanas'ev: Chelating and antiradical effect of rutin during peroxidation of lipids from microsomes and liposomes. Biokhimiia, 53:1660-1666 (1988).
45. Dunn, J. E.: Cancer epidemiology in populations of the United States - with emphasis on Hawaii and California - and Japan. Cancer Res., 35:3240-3245 (1975).
46. Dunnick, J. K. and J. R. Hailey: Toxicity and carcinogenicity studies of quercetin, a natural component of foods. Fundamen. Appl. Toxicol., 19:423-431 (1992).
47. Dwyer, J. T., B. R. Goldin, N. Saul, L. Gualtieri, S. Barakat, and H. Adlercreutz: Tofu and soy drink contain phytoestrogens. J. Am. Diet. Assoc., 94:739-743 (1994)
48. Eaton, E. A., U. K. Walle, A. J. Lewis, T. Hudson, A. A. Wilson, and T. Walle: Flavonoids, potent inhibitors of the human p-form phenolsulfotransferase-potential role in drug metabolism and chemoprevention. Drug Metab. Disp., 24:232-237 (1996).
49. Elangovan, V., N. Sekar, and S. Govindasamy: Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Lett., 87:107-113 (1994).
50. Eldridge, A. C.: Determination of isoflavones in soybean flours, protein concentrates and isolates. J. Agric. Food Chem., 30:353-355 (1982).
51. Evans, B. A. J., K. Griffiths, and M. S. Morton: Inhibition of 5-α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J. Endocrinol., 147:295-302 (1995).
52. Feher, J., G. Csomos, and A. Vereckei: In: Free Radical Reactions in Medicine. Springer-Verlag, Berlin, Germany (1987).
53. Fotsis, T., M. Pepper, H. Adlercreutz, G. Fleischmann, T. Hase, R. Montesano, and L. Schweigerer: Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. U.S.A., 90:2690-2694 (1993).
54. Franceschi, S., A. Favero, C. La Vecchia, E. Negri, E. Conti, M. Montella, A. Giacosa, O. Nanni, and A. Decarli: Food groups and risk of colorectal cancer in Italy. Int. J. Cancer, 72:56-61 (1997).
55. Fukutake, M., M. Takahashi, K. Ishida, H. Kawamura, T. Sugimura, and K. Wakabayashi: Quantification of genistein and genistin in soybeans and soybean products. Food. Chem. Toxicol., 34:457-461 (1996).
56. Gates, J. R., B. Parpia, T. C. Campbell, and J. Chen: Association of dietary factors and selected plasma variables with sex hormone-binding globulin in rural Chinese women. Am. J. Clin. Nutr., 63:22-31 (1996).
57. Gensler, H. L., B. N. Timmermann, S. Valcic, G. A. Wachter, R. Dorr, K. Dvorakova, and D. S. Alberts: Prevention of photocarcinogenesis by topical administration of pure epigallocatechin gallate isolated form green tea. Nutr. Cancer, 26:325-335 (1996).
58. Giri, A. K. and L. J. W. Lu: Genetic damage and the inhibition of 7,12-dimethylbenz[a]anthracene-induced genetic damage by the phytoestrogens, genistein and daidzein, in female ICR mice. Cancer Lett., 95:125-133 (1995).
59. Goldbohm, R. A., M. G. J. Hertog, H. A. M. Brants, G. van Poppel, and P. A. van den Brandt: Consumption of black tea and cancer risk: a prospective cohort study. J. Natl. Cancer Inst., 88:93-100 (1996).
60. Gray, W. G. N., E. E. Biswas, N. Bashirelahi, and S. B. Biswas: A low-affinity estrogen-binding site in pregnant rat uteri: analysis and partial purification. Proc. Natl. Acad. Sci. U.S.A., 91:11502-11506 (1994).
61. Grinberg, L. N., E. A. Rachmilewitz, and H. Newmark: Protective effects of rutin against hemoglobin oxidation. Biochem. Pharmacol., 48:643-649 (1994).
62. Hagiwara, M., S. Inoue, T. Tanaka, K. Nunoki, M. Ito, and H. Hidaka: Differential effects of flavonoids as inhibitors of tyrosine protein kinases and serine/threonine protein kinases. Biochem. Pharmacol., 37:2987-2992 (1988).
63. Havsteen, B.: Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol., 32:1141-1148 (1983).
64. Hawrylewicz E. J., J. J. Zapata, and W. H. Blair: Soy and experimental cancer-animal studies. J. Nutr., 125:S698-S708 (1995).
65. Heilbrun, L. K., A. Nomura, and G. N. Stemmermann: Black tea consumption and cancer risk: a prospective study. Br. J. Cancer, 54:677-683 (1986).
66. Herman, C., T. Adlercreutz, B. R. Goldin, S. L. Gorbach, K. A. V. Hockerstedt, S. Watanabe, E. K. Hamalainen, M. H. Markkanen, T. H. Makela, K. T. Wahala, T. A. Hase, and T. Fotsis: Soybean phytoestrogen intake and cancer risk. J. Nutr., 125:757S-770S (1995).
67. Hertog, M. G. L., P. C. H. Hollman, and M. B. Katan: Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J. Agric. Food Chem., 40:2379-2383 (1992).
68. Hertog, M. G. L., E. J. M. Feskens, P. C. H. Hollman, M. B. Katan, and D. Kromhout: Dietary antioxidant flavonoids and risk of coronary hear disease: The Zutphen Elderly Study. Lancet, 342:1007-1011 (1993).
69. Hertog, M. G. L., P. C. H. Hollman, M. B. Katan, and D. Kromhout: Intake of potential anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr. Cancer, 20:21-29 (1993b).
70. Hertog, M.G.L., E. J. M. Feskens, P. C. H. Hollman, M. B. Katan, and D. Kromhout: Dietary flavonoids and cancer risk in the Zutphen elderly study. Nutr. Cancer, 22:175-184 (1994).
71. Hertog, M. G. L., D. Kromhout, C. Aravanis, H. Blackburn, R. Buzina, F. Fidanza, S. Giampaoli, A. Jansen, A. Menotti, S. Nedeljkovic, M. Pekkarinen, B. S. Simic, H. Toshma, E. J. M. Feskens, P. C. H. Hollman, and M. B. Katan: Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch. Intern. Med., 155:381-386 (1995).
72. Hirohata, T. and S. Kono: Diet/nutrition and stomach cancer in Japan. Int. J. Cancer, 10S:34-36 (1997).
73. Hirano, T., M. Gotoh, and K. Oka: Natural flavonoids and lignans are potent cytostatic agents against human leukemic HL-60 cells. Life Sci., 55:1061-1069 (1994).
74. Hirano, T., K. Abe, M. Gotoh, and K. Oka: Citrus flavone tangeretin inhibits leukemia HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br. J. Cancer, 72:1380-1388 (1995).
75. Hirose, M., T. Hoshiya, K. Akagi, M. Futakuchi, and N. Ito: Inhibition of mammary gland carcinogenesis by green tea catechins and other naturally occurring antioxidants in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz[a]anthracene. Cancer Lett., 83:149-156 (1994).
76. Ho, S.-M., T. Viccione, and M. Yu: In vitro and in vivo inhibition of nuclear type II estrogen binding sites in the dorsolateral prostate of Noble rats. J. Steroid Biochem. Mol. Biol., 46:489-495 (1993).
77. Ho, S.-M. and M. Yu: Selective elevation of type II estrogen receptor levels in the dysplastic dorsolateral prostates of Noble rats. Cancer Res., 53:528-532 (1993).
78. Ho, S.-M. and M. Yu: Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral pros- tate of Noble rats. J. Steroid Biochem. Mol. Biol., 52:233-238 (1995).
79. Hoffman, R., L. Graham, and E. S. Newlands: Enhanced anti-proliferative action of busulphan by quercetin on the human leukemia cell line K562. Br. J. Cancer, 59:347-348 (1989).
80. Hofmann, J., H. F. Fiebig, B. R. Winterhalter, D. P. Berger, and H. Grunicke: Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int. J. Cancer, 45:536-539 (1990).
81. Hoffman, R.: Potent inhibition of breast cancer cell lines by the isoflavonoid kievitone: comparison with genistein. Biochem. Biophys. Res. Comm., 211:600-606 (1995).
82. Hollman, P. C. H., J. H. M. de Vries, S. D. van Leeuwen, M. J. B. Mengelers, and M. B. Katan: Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr., 62:1276-1282 (1995).
83. Hosokawa, N., K. Hirayoshi, A. Nakai, Y. Hosokawa, N. Marui, M. Yoshida, T. Sakai, H. Nishino, A. Aoike, K. Kawai, and K. Nagata: Flavonoids inhibit the espression of heat shock proteins. Cell Struc. Funct., 15:393-401 (1990).
84. Hosokawa, N., Y. Hosokawa, T. Sakai, M. Yoshida, N. Marui, H. Nishino, K. Kawai, and A. Aoike: Inhibitory effect of quercetin on the synthesis of a possibly cell-cycle-related 17-kDa protein, in human colon cancer cells. Int. J. Cancer, 45:1119-1124 (1990b).
85. Hursting, S. D., S. N. Perkins, D. C. Haines, J. M. Ward, and J. M. Phang: Chemoprevention of spontaneous tumorigenesis in p53-knockout mice. Cancer Res., 55:3949-3953 (1995).
86. Ingram, D., K. Sanders, M. Kolybaba, and D. Lopez: Case-control study of phyto-oestrogens and breast cancer. Lancet, 350:990-994 (1997).
87. Jan, C., U. Takahama, and M. Kimura: Inhibition of photooxidation of α-tocopherol by quercetin in human blood cell membranes in the presence of hematoporphyrin as a photosensitizer. Biochim. Biophys. Acta, 1086:7-14 (1991).
88. Ji, B. T., W. H. Chow, G. Yang, J. K. McLaughlin, R. N. Gao, W. Zheng, X. O. Shu, F. Jin, J. F. Fraumeni, Jr., and Y. T. Gao: The influence of cigarette smoking, alcohol, and green tea consumption on the risk of carcinoma of the cardiac and distal stomach in Shanghai, China. Cancer, 77:2449-2457 (1996).
89. Ji, B. T., W. H. Chow, A. W. Hsing, J. K. McLaughlin, Q. Dai, Y. T, Gao, W. J. Blot, and J. F. Fraumeni, Jr.: Green tea consumption and the risk of pancreatic and colorectal cancers. Int. J. Cancer, 70:255-258 (1997).
90. Katiyar, S. K., N. J. Korman, H. Mukhtar, and R. Agarwal: Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J. Natl. Cancer Inst., 89:556-566 (1997).
91. Katiyar, S. K., R. R. Mohan, R. Agarwal, and H. Mukhtar: Protection against induction of mouse skin papillomas with low and high risk of converstion to malignancy by green tea polyphenols. Carcinogenesis, 18:497-502 (1997b).
92. Kawamori, T., T. Tanaka, A. Hara, J. Yamahara, and H. Mori: Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats. Cancer Res., 55:1277-1282 (1995).
93. Kelley, S. L., A. Basu, B. A. Teicher, M. P. Hacker, D. H. Hamer, and J. S. Lazo: Overexpression of metallothionein confers resistance to anticancer drugs. Science, 241:1813-1815 (1988).
94. Keung, W. M.: Dietary estrogenic isoflavones are potent inhibitors of β-hydroxysteroid dehydrogenase of testosterone. Biochem. Biophys. Res. Comm., 215:1137-1144 (1995).
95. Kioka, N., N. Hosokawa, T. Komano, K. Hirayoshi, K. Nagata, and K. Ueda: Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite. FEBS, 301:307-309 (1992).
96. Knekt, P., R. Jarvinen, R. Seppanen, M. Heliovaara, L. Teppo, E. Pukkala, and A. Aromaa: Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am. J. Epidemiol., 146:223-230 (1997).
97. Komatsu, K., H. Tauchi, N. Yano, S. Endo, S. Matsuura, and S. Shoji: Inhibitory action of (-)-epigallocatechin gallate on radiation-induced mouse oncogenic transformation. Cancer Lett., 112:135-139 (1997).
98. Kootstra, A: Protection from UV-B-induced DNA damage by flavonoids. Plant Mol Biol., 26:771-774 (1994).
99. Kuhnau, J.: The flavonoids, a class of semi-essential food components, their role in human nutrition. World Rev. Nutr. Diet, 24:117-120 (1976).
100. Kuo, S.-M.: Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett., 110:41-48 (1996).
101. Kuo, S.-M. and P. Leavitt: Dietary flavonoids and gene expression in human intestinal cells. FASEB J., 11:A1200 (1997).
102. Kuo, S.-M., P. S. Leavitt, and C.-P. Lin: Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells. Biol. Trace Element Res., in press (1998).
103. Kyle, E., L. Neckers, C. Takimoto, G. Curt, and R. Bergan: Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol. Pharmacol., 51:193-200 (1997).
104. Lamartiniere, C. A., J. B. Moore, N. M. Brown, R. Thompson, M. J. Hardin, and S. Barnes: Genistein suppresses mammary cancer in rats. Carcinogenesis, 16:2833-2840 (1995).
105. Larocca, L. M., M. Giustacchini, N. Maggiano, F. O. Ranelletti, M. Piantelli, E. Alcini, and A. Capelli: Growth-inhibitory effect of quercetin and presence of type II estrogen binding sites in primary human transitional cell carcinomas. J. Urol., 152:1029-1033 (1994).
106. Laughton, M. J., B. Halliwell, P. J. Evans, and J. R. Hoult: Antioxidant and pro-oxidant actions of the plant phenolics quercetin, gossypol and myricetin. Effects on lipid peroxidation, hydroxyl radical generation and bleomycin-dependent damage to DNA. Biochem. Pharmacol., 38:2859-2865 (1989).
107. Lee, K. W., H. J. Wang, P. A. Murphy, and S. Hendrich: Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver. Nutr. Cancer, 24:267-278 (1995).
108. Lee, W. M., A. S. T. Wong, A. W. K. Tu, C. H. Cheung, J. C. H. Li, and G. L. Hammond: Rabbit sex hormone binding globulin-primary structure, tissue expression, and structure/function analyses by expression in Escherichia coli. J. Endocrinol., 153:373-384 (1997).
109. 2 and N-acetyl-L-cysteine regulate expression of c-jun and c-fos in lens systems. Exp. Eye Res., 59:179-190 (1994).
110. Liao, S., Y. Umekita, J. Guo, J. M. Kokontis, and R. A. Hiipakka: Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechingallate. Cancer Lett., 96:239-243 (1995).
111. 2-terminal kinases. J. Biol. Chem., 271:15703-15707 (1996).
112. Lu, L. J. W., K. E. Anderson, J. J. Grady, and M. Nagamani: Effects of soya consumption for one month on steroid hormones in premenopausal women - implications for breast cancer risk reduction. Cancer Epidemiol. Biomarkers Prev., 5:63-70 (1996).
113. Lu, L. J. W., J. J. Grady, M. V. Marshall, V. M. S. Ramanijam, and K. E. Anderson: Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects. Nutr. Cancer, 24:311-323 (1995).
114. Magee, A. C.: Biological responses of young rats fed diets containing genistin and genistein. J. Nutr., 80:151-156 (1963).
115. Makela, S., V. Davis, W. C. Tally, J. Korkman, L. Salo, R. Vihko, R. Santti, and K. S. Korach: Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ. Health Perspect., 102:572-578 (1994).
116. Makela, S., L. H. Pylkkanen, R. S. S. Santti, and H. Adlercreutz: Dietary soybean may be antiestrogenic in male mice. J. Nutr., 125:437-445 (1995a).
117. Makela, S., R. Santti, L. Salo, and J. A. McLachlan: Phytoestrogens are partial estrogen agonists in the adult male mouse. Environ. Health Perspect., 103S:123-127 (1995b).
118. Manach, C., C. Morand, O. Texier, M. L. Favier, G. Agullo, C. Demigne, F. Regerat, and C. Remesy: Quercetin metabolites in plasma of rats fed diets containing rutin or quercetin. J. Nutr., 125:1911-1922 (1995).
119. Markovits, J., C. Linassier, P. Fosse, J. Couprie, J. Pierre, A. Jacquemin-Sablon, J. Saucier, J. Le Pecq, and A. K. Larsen: Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 49:5111-5117 (1989).
120. Markaverich, B. M., R. R. Roberts, M. A. Alejandro, G. A. Johnson, B. S. Middleditch, and J. H. Clark: Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J. Steroid Biochem., 30:71-78 (1988).
121. Markaverich, B. M. and R. R. Gregory: Preliminary assessment of luteolin as an affinity ligand for type II estrogen-binding sites in rat uterine nuclear extracts. Steroids, 58:268-274 (1993).
122. Martin, J. P., Jr.: Assays for Superoxide dismutase based on autooxidation of hematoxylin. Method. Enzymol., 186:220-227 (1990).
123. Matsukawa, Y., H. Nishino, Y. Okuyama, T. Matsui, T. Matsumoto, S. Matsumura, Y. Shimizu, Y. Sowa, and T. Sakai: Effects of quercetin and/or restrain stress on formation of aberrant crypt foci induced by azoxymethane in rat colons. Oncology, 54:118-121 (1997).
124. McLellan, L. I., L. A. Kerr, A. D. Cronshae, and J. D. Hayes: Regulation of mouse glutathione S-transferase by chemoprotectors. Biochem. J., 276:461-469 (1991).
125. Messina, M. J., V. Persky, K. D. R. Setchell, and S. Barnes: Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer, 21:113-131 (1994).
126. Mettlin, C.: Milk drinking, other beverage habits, and lung cancer risk. Int. J. Cancer, 43:608-612 (1989).
127. Middleton, E. Jr. and C. Kandaswami: The importance of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: The Flavonoids: Advances in Research Since 1986 (J. B. Harborne Eds.) Chapman & Hall, London, 619-652 (1993).
128. Miksicek, R. J.: Commonly occurring plant flavonoids have estrogenic activity. Molec. Pharmacol., 44:37-43 (1993).
129. Miksicek, R. J.: Estrogenic flavonoids: structural requirements for biological activity. Proc. Soc. Exp. Biol. Med., 208:44-50 (1995).
130. Millin, D. J., Crispin, D. J., and D. Swaine: Non-volatile components of black tea and their contribution to the character of the beverage. J. Agric. Food Chem., 17:717-719 (1969).
131. Mills, P. K., W. L. Beeson, R. L. Phillips, and G. E. Fraser: Cohort study of diet, life style and prostate cancer in Adventist men. Cancer, 64:598-604 (1989).
132. Monti, E. and B. K. Sinha: Antiproliferative effect of genistein and adriamycin against estrogen-dependent and -independent human breast carcinoma cell lines. Anticancer Res., 413A: 1221-1226 (1994).
133. Morel, I., G. Lescoat, P. Cogrel, O. Sergent, N. Pasdeloup, P. Brissot, P. Cillard, and J. Cillard: Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem. Pharmacol., 45:13-19 (1993).
134. Mousavi, Y. and H. Adlercreutx: Genistein is an effective stimulator of sex hormone-binding globulin production in hepatocarcinoma human liver cancer cells and suppresses proliferation of these cells in culture. Steroids, 58:301-304 (1993).
135. Murrill, W. B., N. M. Brown, J. X. Zhang, P. A. Manzolillo, S. Barnes, and C. A. Lamartiniere: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis, 17:1451-1457 (1996).
136. Naik, H. R., J. E. Lehr, and K. J. Pienta: An in vitro and in vivo study of antitumor effects of genistein on hor- mone refractory prostate cancer. Anticancer Res., 14:2617-2619 (1994).
137. Negre-Salvayre, A., A. Affany, C. Hariton, and R. Salvayre: Additional antilipoperoxidant activities of α-tocopherol and ascorbic acid on membrane-like systems are potentiated by rutin. Pharmacology, 42:262-272 (1991).
138. Ohno, Y., K. Wakai, K. Genka, K. Ohmine, T. Kawamura, A. Tamakoshi, R. Aoki, M. Senda, Y. Hayashi, K. Nagao, S. Fukuma, and K. Aoki: Tea consumption and lung cancer risk: a case-control study in Okinawa, Japan. Jpn. J. Cancer Res., 86:1027-1034 (1995).
139. Okabe, S., M. Suganuma, M. Hayashi, E. Sueoka, A. Komori, and H. Fujiki: Mechansims of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res., 88:639-643 (1997).
140. Okura, A., H. Arakawa, H. Oka, T. Yoshinari, and Y. Monden: Effect of genistein on topoisomerase activity and on the growth of [Val12]Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Comm., 157:183-189 (1988).
141. O'Sullivan, MG., R. M. Bostick, L. D. Case, M. J. Jayo, and A. L. Waterhouse: Modulation of colon cell proliferation in monkeys by isoflavone-rich soy protein- and grape phenol-based diets. Proc. Am. Assoc. Cancer Res., 38:110 (1997).
142. Pamukcu, A. M., S. Yalciner, J. F. Hatcher, and G. T. Bryan: Quercetin, a rat intestinal and bladder carcinogen present in Bracken Fern. Cancer Res., 40:3468-3472 (1980).
143. Pagliacci M. C., M. Smacchia, G. Migliorati, F. Grignani, C. Riccardi, and I. Nicoletti: Growth inhibitory effects of the natural phyto-estrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer, 30A:1675-1682 (1994).
144. Pereira, M. A., C. J. Grubbs, L. H. Barnes, H. Li, G. R. Olson, I. Eto, M. Juliana, L. M. Whitaker, G. J. Kelloff, V. E. Steele, and R. A. Lubet: Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced mammary cancer in rats. Carcinogenesis, 17:1305-1311 (1996).
145. Peterson, G., and S. Barnes: Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Comm., 179:661-667 (1991).
146. Peterson, G. and S. Barnes: Genistein and biochanin A inhibit the growth of human prostate cancer cells but not epidermal growth factor receptor tyrosine autophosphorylation. Prostate, 22:335-345 (1993).
147. Peterson, G.: Evaluation of the biochemical targets of genistein in tumor cells. J. Nutr., 125:784S-789S (1995).
148. Peterson, G., L. Coward, M. Kirk, C. N. Falany, and S. Barnes: The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis, 17:1861-1869 (1996).
149. Peterson, G., and S. Barnes: Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ., 7:1345-1351 (1996).
150. Piantelli, M., A. Rinelli, E. Macri, N. Magiano, L. Larocca, M. Scerrati, R. Roselli, M. Larocca, M. Scerrati, R. Roselli, M. Iacoangeli, G. Scambia, A. Capelli, and F. O. Ranelletti: Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer, 71:193-198 (1993).
151. Piantelli, M., N. Maggiano, R. Ricci, L. M. Larocca, A. Capelli, G. Scambia, G. Isola, P. G. Natali, and F. Ranelletti: Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J. Invest. Dermatol., 105:248-253 (1995).
152. Pierpoint, W.S.: Flavonoids in the human diet. In: Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships (V. Cody, E. Middleton and J. B. Horborne, Eds.) Alan R. Liss, New York, 125-140 (1986).
153. Pollard, M. and P. H. Luckert: influence of isoflavones in soy protein isolates on development of induced prostate-related cancers in L-W rats. Nutr. Cancer, 28:41-45 (1997).
154. Potter, S. M., J. Pertile, and M. D. Berber-Jimenez: Soy protein concentrate and isolated soy protein similarly lower blood serum cholesterol but differently affect thyroid hormones in hamsters. J. Nutr., 126:2007-2011 (1996).
155. Pylkkanen, L., R. Santti, R. Newbold, and J. A. McLachlan: Regional differences in the prostate of the neonatally estrogenized mouse. Prostate, 18:117-129 (1991).
156. Pylkkanen, L., S. Makela, E. Valve, P. Harkonen, and R. Santti: Prostatic dysplasia associated with increased expression of c-myc in neonatally estrogenized mice. J. Urol., 149:1593-1601 (1993).
157. Rahman, A., Shahabuddin, S. M. Hadi, J. H. Parish, and K. Ainley: Strand scission in DNA induced by quercetin and Cu(II): role of Cu(I) and oxygen free radicals. Carcinogenesis, 10:1833-1839 (1989).
158. Rahman, A., Shahabuddin, S. M. Hadi, and J. H. Parish: Complexes involving quercetin, DNA and Cu(II). Carcinogenesis, 11:2001-2003 (1990).
159. Rahman, A., F. Fazal, J. Greensill, K. Ainley, J. H. Parish, and S. M. Hadi: Strand scission in DNA induced by dietary flavonoids: role of Cu(I) and oxygen free radicals and biological consequences of scission. Mol. Cell. Biochem., 111:3-9 (1992).
160. Record, I. R., I. E. Dreosti, and J. K. McInerney: The antioxidant activity of genistein in vitro. J. Nutr. Biochem., 6:481-485 (1995).
161. Ranelletti, F. O., R. Ricci, L. M. Larocca, N. Maggiano, A. Capelli, G. Scambia, P. Benedetti-Panici, S. Mancuso, C. Rumi, and M. Piantelli: Growth-inhibitory effect of quercetin and presence of type II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int. J. Cancer, 50:486-492 (1992).
162. Rao, C. V., C.-X. Wang, B. Simi, R. Lubet, G. Kelloff, V. Steele, and B. S. Reddy: Enhancement of experimental colon cancer by genistein. Cancer Res., 57:3717-3722 (1997).
163. Robak J. and R. J. Gryglewski: Flavonoids are scavengers of Superoxide anions. Biochem. Pharmacol., 37:837-841 (1988).
164. Robinson, M. J., A. H. Corbett, and N. Osheroff: Effects of topoisomerase-II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis -evidence of distinct drug interaction domains on topoisomerase-II. Biochemistry, 32:3638-3643 (1993).
165. Rokhlin, O. W. and M. B. Cohen: Differential sensitivity of human prostatic cancer cell lines to the effects of protein kinase and phosphatase inhibitors. Cancer Lett., 98:103-110 (1995).
166. Rose, D. P., A. P. Boyar, and E. L. Wynder. International comparison of mortality rates for cancer of the breast, ovary, prostate and colon and per capita food consumption. Cancer, 58:2363-2371 (1986).
167. Rusznyak, S. P. and A. Szent-Gyorgyi: Vitamin P: flavonols as vitamins. Nature, 138:27 (1936).
168. Sahu, S. C. and G. C. Gray: Interactions of flavonoids, trace metals, and oxygen: nuclear DNA damage and lipid peroxidation induced by myricetin. Cancer Lett., 70:73-79 (1993).
169. Sahu, S.C. and G. C. Gray: Kaempferol-induced nuclear DNA damage and lipid peroxidation. Cancer Lett., 85:159-164 (1994).
170. Said Ahmad, A., F. Fazal, A. Rahman, S. M. Hadi, and J. H. Parish: Activities of flavonoids for the cleavage of DNA in the presence of Cu(II): correlation with generation of active oxygen species. Carcinogenesis, 13:605-608 (1992).
171. Said Ahmed, M., K. Ainley, J. H. Parish, and S. M. Hadi: Free radical-induced fragmentation of proteins by quercetin. Carcinogenesis, 15:1627-1630 (1994).
172. Said Ahmed, M., V. Ramesh, V. Nagaraja, J. H. Parish, and S. M. Hadi: Mode of binding of quercetin to DNA. Mutagenesis, 9:193-197 (1994b).
173. Saija, A., M. Scalese, M. Lanza, D. Marzullo, F. Bonina, and F. Castelli: Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic. Biol. Med., 19:481-486 (1995).
174. Santell, R. C., Y. C. Chang, M. G. Nair, and W. G. Helferich: Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J. Nutr., 127:263-269 (1997).
175. Santibanez, J. F., A. Navarro, and J. Martinez: Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines. Anticancer Res., 17:1199-1204 (1997).
176. Sanz, M. J., M. L. Ferrandiz, M. Cejudo, M. C. Terencio, B. Gil, G. Bustos, A. Ubeda, R. Gunasegaran, and M. J. Alcaraz: Influence of a series of natural flavonoids on free radical generating systems and oxidative stress. Xenobiotica, 24:689-699 (1994).
177. Sarkar, M. A.: Quercetin not only inhibits p-glycoprotein efflux activity but also inhibits CYP3A isozymes. Cancer Chemother. Pharmacol., 36:448-450 (1995).
178. Sathyamoorthy, N., T. T. Y. Wang, and J. M. Phang: Stimulation of pS2 expression by diet-derived compounds. Cancer Res., 54:957-961 (1994).
179. Scambia, G., F. O. Ranelletti, P. Benedetti-Panici, M. Piantelli, G. Bonanno, R. De Vincenzo, G. Ferrandina, L. Pierelli, A. Capelli, and S. Mancuso: Quercetin inhibits the growth of a multidrug-resistant estrogen receptor-negative MCF-7 human breast cancer cell line expressing type II estrogen-binding sites. Cancer Chemother. Pharmacol., 28:255-258 (1991).
180. Scambia, G., F. O. Ranelletti, P. Benedetti-Panici, M. Piantelli, R. De Vincenzo, G. Ferrandina, G. Bonanno, A. Capelli, and S. Mancuso: quercetin induces type II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast cancer cell lines. Int. J. Cancer, 54:462-466 (1993).
181. Scambia, G., P. B. Panici, F. O. Ranelletti, G. Ferrandina, R. De Vincenzo, M. Piantelli, V. Masciullo, G. Bonanno, G. Isola, and S. Mancuso: Quercetin enhances transforming growth factor β1 secretion by human ovarian cancer cells. Int. J. Cancer, 57:211-215 (1994).
182. Scambia, G., F. O. Ranelletti, P. B. Panici, R. De Vincenzo, G. Bonanno, G. Ferrandina, M. Piantelli, S. Bussa, C. Rumi, M. Cianfriglia, and S. Mancuso: quercetin potentiates the effect of andriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol., 34:459-464 (1994).
183. Scambia, G., R. De Vincenzo, F. O. Ranelletti, P. B. Panici, G. Ferrandina, G. D'Agostino, A. Fattorossi, E. Bombardelli, and S. Mancuso: Antiproliferative effect of silybin on gynaecological malignancies: synergism with cisplatin and doxorubicin. Eur. J. Cancer, 32A:877-882 (1996).
184. Scholar, E. M. and M. L. Toews: Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett., 87:159-162 (1994).
185. Schreck, R. and P. A. Baeuerle: Assessing oxygen radicals as mediators in activation of inducible eukaryotic transcription factor NF-κB. Method. Enzymol., 234:151-163 (1994).
186. Severson, R. K., A. Y. M. Nomura, J. S. Grove, and G. N. Stemmerman: A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res., 49:1857-1860 (1989).
187. Shimizu, H., R. K. Ross, L. Bernstein, R. Yatani, B. E. Henderson, and T. M. Mack: Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles county. Br. J. Cancer, 63:963-966 (1991).
188. Shimoi, K., S. Masuda, M. Furugori, S. Esaki, and N. Kinae: Radioprotective effect of antioxidative flavonoids in γ-ray irradiated mice. Carcinogenesis, 15:2669-2672 (1994).
189. Shutt, D. A.: Interaction of genistein with estradiol in the reproductive tract of the ovariectomized mouse. J. Endocrinol., 37:231-232 (1967).
190. Sliutz, G., J. Karlseder, C. Tempfer, L. Orel, G. Holzer, and N. M. Simon: Drug resistance against gemcitabine and topotecan mediated by constitutive hsp70 overexpression in vitro: implication of quercetin as sensitiser in chemotherapy. Br. J. Cancer, 74:172-177 (1996).
191. So, F. V., N. Guthrie, A. F. Chambers, M. Moussa, and K .K. Carroll: Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr. Cancer, 26:167-181 (1996).
192. So, F. V., N. Guthrie, A. F. Chambers, and K. K. Carroll: Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett., 112:127-133 (1997).
193. Song, L., J. W. Kosmeder, C. Gerhauser, M. Hawthorne, R. G. Mehta, R. C. Moon, R. M. Moriarty, and J. M. Pezzuto: Potent induction of phase II enzymes by flavones and chalcones. Proc. Am. Assoc. Cancer Res., 38:366 (1997).
194. Spinozzi, F., M. C. Pagliacci, and G. Migliorati: The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leukemia Res., 18:431-439 (1994).
195. Stapleton, A. E. and V. Walbot: Flavonoids can protect maize DNA from the induction of ultrviolet radiation damage. Plant Physiol., 105:881-889 (1994).
196. Steele V. E., M. A. Pereira, C. C. Sigman, and G. J. Kelloff: Cancer chemoprevention agent development strategies for genistein. J. Nutr., 125:S713-S716 (1995).
197. Tanaka, T., H. Makita, M. Ohnishi, H. Mori, K. Satoh, A. Hara, T. Sumida, K. Fukutani, T. Tanaka, and H. Ogawa: Chemoprevention of 4-nitroquinoline l-oxide-induced oral carcinogenesis in rats by flavonoids, diosmin and hesperidine, each alone and in combination. Cancer Res., 57:246-252 (1997).
198. Teofili, L., L. Pierelli, M. S. Iovino, G. Leone, G. Scambia, R. De Vincenzo, P. Benedetti-Panici, G. Menichella, E. Macri, and M. Pianteelli: The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leukemia Res., 16:497-503 (1992).
199. Thigpen, J. E., L. Li, C. B. Richter, E. H. Lebetkin, and C. W. Jameson: The mouse bioassay for the detection of estrogenic activity in rodent diets. II. Comparative estrogenic activity of purified, certified and standard open and closed formula rodent diets. Lab. Anim. Sci., 37:602-605 (1987).
200. Thompson, M., C. R. Williams, and G. E. Elliot: Stability of flavonoid complexes of copper(II) and flavonoids antioxidant activity. Anal. Chim. Acta, 85:375-381 (1976).
201. Ullrich, A. and J. Schlessinger: Signal transduction by receptors with tyrosine kinase activity. Cell, 61:203-212 (1990).
202. Verma, A.K., J. A. Johnson, M. N. Gould, and M. A. Tanner: Inhibition of 7,12-dimethylbenz[a]antrracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res., 48:5754-5758 (1988).
203. Verma, S. P., E. Salamone, and B. Goldin: Cucurmin and genistein, plant natural products, show synergistic inhibitory effects on the growth of human breast cancer MCF-7 cells induced by estrogen pesticides. Biochem. Biophys. Res. Comm., 233:692-296 (1997).
204. Versantvoort, C. H. M., G. J. Schuurhuis, H. M. Pinedo, C. A. Eekman, C. M. Kuiper, J. Lankelma, and H. J. Broxterman: Genistein modulates the decreased drug accumulation in non-p-glycoprotein mediated multidrug resistant tumour cells. Br. J. Cancer, 68:939-946 (1993).
205. Walter, E. D.: Genistin (an isoflavone glucoside) and its aglucone, genistein, from soybeans. J. Am. Chem. Soc., 63:3273-3276 (1941).
206. Wang, H.-J. and P. A. Murphy: Isoflavone content in commercial soybeanfoods. J. Agric.Food.Chem., 42:1666-1673 (1994).
207. Wang, T. T. Y., N. Sathyamoorthy, and J. M. Phang: Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17:271-275 (1996).
208. Wang, Z. Y., M. T. Huang, Y. R. Lou, J. G. Xie, K. R. Reuhl, H. L. Newmark, C. T. Ho, C. S. Yang, and A. H. Conney: Inhibitory effects of black tea, green tea, decaffinated black tea and decaffinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res., 54:3428-3435 (1994).
209. Watanabe, T., T. Shiraishi, H. Sasaki, and M. Oishi: Inhibitors of protein-tyrosine kinases, ST638 and genistein, induce differentiation of mouse erythroleukemia cells in a synergistic manner. Exp. Cell Res., 183:335-342 (1989).
210. Watanabe, T., K Kondo, and M. Oishi: Induction of in vitro differentiation of mouse erythroleukemia cells by genistein, an inhibitor of tyrosine protein kinases. Cancer Res., 51:764-768 (1991).
211. Wei, H., L. Tye, E. Bresnick, and D. F. Birt: Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res., 40:499-502 (1990).
212. Wei, H., L. Wei, K. Frenkel, R. Bowen, and S. Barnes: Inhibition of tumor promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr. Cancer, 20:1-12 (1993).
213. Wei, H., R. Bowen, Q. Y. Cai, S. Barnes, and Y. Wang: Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med., 208:124-130 (1995).
214. Wei, H., S. Barnes, and Y. Wang: Inhibitory effct of genistein on a tumor promoter-induced c-fos and c-jun expression in mouse skin. Oncol. Rep., 3:125-128 (1996).
215. Wood, A. W., D. S. Smith, R. L. Chang, M.-T. Huang, and A. H. Conney: Effects of flavonoids on the metaoblism of xenobiotics. In: Plant Flavonoids in Biology and Medicine: Biochemical, Pharmacological, and Structure-Activity Relationships (V. Cody, E. Middleton and J. B. Horborne, Eds.) Alan R. Liss, New York, 195-210 (1986).
216. Yanagihara, K., A. Ito, T. Toge, and M. Numoto: Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res., 53:5815-5821 (1993).
217. Yasuda, T., S. Mizunuma, Y. Kano, K. Saito, and K. Ohsawa: Urinary and biliary metabolites of genistein in rats. Biol. Pharmacol. Bull., 19:413-417 (1996).
218. Yeh, Y. A., M. Herenyiova, and G. Weber: Quercetin-synergistic action with carboxyamidotriazole in human breast carcinoma cells. Life Sci., 57:1285-1292 (1995).
219. Yin, P. Z., J. Y. Zhao, S. J. Cheng, Y. Hara, Q. F. Zhu, and Z. G. Liu: Experimental studies of the inhibitory effects of green tea catechin on mice intestinal cancers induced by 1,2-dimethylhydrazine. Cancer Lett., 79:33-38 (1994).
220. Yokoo, T. and M. Kitamura: Unexpected protection of glomerular mesangial cells from oxidant-triggered apoptosis by bioflavonoid quercetin. Am. J. Physiol, 42:F206-F212 (1997).
221. Yu, G. P., C. C. Hsieh, L. Y. Wang, S. Z, Yu, X. L. Li, and T. H. Jin: Green tea consumption and risk of stomach cancer: a population-based case-control study in Shanghai, China. Cancer Causes Control, 6:532-538 (1995).
222. Zeva, D. T. and G. Duwe: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer, 27:31-40 (1997).
223. Zheng, W., T. J. Doyle, L. H. Kushi, T. A. Sellers, C. P. Hong, and A. R. Folsom: Tea consumption and cancer incidence in a prospecive cohort study of postmenopausal women. Am. J. Epidemiol., 144:175-182 (1996).